Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
266,941,931
-
Total 13F shares
-
7,115,554
-
Share change
-
-70,452
-
Total reported value
-
$82,816,339
-
Price per share
-
$11.64
-
Number of holders
-
55
-
Value change
-
-$6,653,680
-
Number of buys
-
30
-
Number of sells
-
21
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q4 2014
As of 31 Dec 2014,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,115,554 shares.
The largest 10 holders included
Novo A/S, EAGLE ASSET MANAGEMENT INC, HealthCor Management, L.P., FMR LLC, RA CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BALYASNY ASSET MANAGEMENT LLC, MORGAN STANLEY, and Cormorant Asset Management, LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.